XML 27 R17.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Derivatives and Hedging Activities
6 Months Ended
Jun. 30, 2011
Derivatives and Hedging Activities  
Derivatives and Hedging Activities

12.  Derivatives and Hedging Activities

 

Derivative instruments enable the Company to manage its exposure to various market risks. The value of such instruments is derived from an underlying variable or multiple variables, including equity, foreign exchange and interest rate indices or prices. The Company primarily enters into derivative agreements for risk management purposes related to the Company’s products and operations.

 

The Company uses derivatives as economic hedges and accounting hedges. The following table presents the balance sheet location and the gross fair value of derivative instruments, including embedded derivatives:

 

 

 

 

 

Asset

 

 

 

Liability

 

Derivatives designated 

 

Balance Sheet

 

June 30,

 

December 31,

 

Balance Sheet

 

June 30,

 

December 31,

 

as hedging instruments

 

Location

 

2011

 

2010

 

Location

 

2011

 

2010

 

 

 

 

 

(in millions)

 

 

 

(in millions)

 

Cash flow hedges

 

 

 

 

 

 

 

 

 

 

 

 

 

Asset-based distribution fees

 

Other assets

 

$

 

$

10

 

Other liabilities

 

$

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair value hedges

 

 

 

 

 

 

 

 

 

 

 

 

 

Fixed rate debt

 

Other assets

 

82

 

61

 

Other liabilities

 

 

 

Total qualifying hedges

 

 

 

82

 

71

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivatives not designated as hedging instruments

 

 

 

 

 

 

 

 

 

 

 

 

 

GMWB and GMAB

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate contracts

 

Other assets

 

464

 

366

 

Other liabilities

 

451

 

379

 

Equity contracts

 

Other assets

 

342

 

354

 

Other liabilities

 

780

 

665

 

Credit contracts

 

Other assets

 

1

 

4

 

Other liabilities

 

1

 

1

 

Foreign currency contracts

 

Other assets

 

2

 

 

Other liabilities

 

2

 

 

Embedded derivatives(1)

 

N/A

 

 

 

Future policy benefits and claims

 

316

 

421

 

Total GMWB and GMAB

 

 

 

809

 

724

 

 

 

1,550

 

1,466

 

Other derivatives:

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate lock commitments

 

Other assets

 

 

1

 

Other liabilities

 

 

 

Equity

 

 

 

 

 

 

 

 

 

 

 

 

 

EIA

 

Other assets

 

 

1

 

Other liabilities

 

 

 

EIA embedded derivatives

 

N/A

 

 

 

Future policy benefits and claims

 

2

 

3

 

Stock market certificates

 

Other assets

 

71

 

89

 

Other liabilities

 

61

 

75

 

Stock market certificates embedded derivatives

 

N/A

 

 

 

Customer deposits

 

10

 

14

 

Ameriprise Financial Franchise Advisor Deferred Equity Plan

 

Other assets

 

8

 

8

 

Other liabilities

 

 

 

Foreign exchange

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency

 

Other assets

 

1

 

1

 

Other liabilities

 

 

1

 

Total other

 

 

 

80

 

100

 

 

 

73

 

93

 

Total non-designated hedges

 

 

 

889

 

824

 

 

 

1,623

 

1,559

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total derivatives

 

 

 

$

971

 

$

895

 

 

 

$

1,623

 

$

1,559

 

 

 

N/A  Not applicable.

(1) The fair values of GMWB and GMAB embedded derivatives fluctuate based on changes in equity, interest rate and credit markets.

 

See Note 11 for additional information regarding the Company’s fair value measurement of derivative instruments.

 

Derivatives Not Designated as Hedges

 

The following table presents a summary of the impact of derivatives not designated as hedging instruments on the Consolidated Statements of Operations:

 

 

 

 

 

Amount of Gain (Loss) on

 

 

 

 

 

Derivatives Recognized in Income

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

Derivatives not designated as

 

Location of Gain (Loss) on

 

June 30,

 

June 30,

 

hedging instruments

 

Derivatives Recognized in Income

 

2011

 

2010

 

2011

 

2010

 

 

 

 

 

(in millions)

 

GMWB and GMAB

 

 

 

 

 

 

 

 

 

 

 

Interest rate contracts

 

Benefits, claims, losses and settlement expenses

 

$

87

 

$

185

 

$

62

 

$

211

 

Equity contracts

 

Benefits, claims, losses and settlement expenses

 

5

 

747

 

(250

)

574

 

Credit contracts

 

Benefits, claims, losses and settlement expenses

 

(5

)

(20

)

(7

)

(30

)

Foreign currency contracts

 

Benefits, claims, losses and settlement expenses

 

(4

)

 

(6

)

 

Embedded derivatives(1)

 

Benefits, claims, losses and settlement expenses

 

(125

)

(890

)

105

 

(784

)

Total GMWB and GMAB

 

 

 

(42

)

22

 

(96

)

(29

)

Other derivatives:

 

 

 

 

 

 

 

 

 

 

 

Interest rate

 

 

 

 

 

 

 

 

 

 

 

Interest rate lock commitments

 

Other revenues

 

 

 

(1

)

 

Equity

 

 

 

 

 

 

 

 

 

 

 

GMDB

 

Benefits, claims, losses and settlement expenses

 

 

8

 

 

5

 

EIA

 

Interest credited to fixed accounts

 

(1

)

(1

)

 

 

EIA embedded derivatives

 

Interest credited to fixed accounts

 

1

 

4

 

1

 

6

 

Stock market certificates

 

Banking and deposit interest expense

 

 

(5

)

3

 

(2

)

Stock market certificates embedded derivatives

 

Banking and deposit interest expense

 

1

 

5

 

(2

)

2

 

Seed money

 

Net investment income

 

 

5

 

(3

)

3

 

Ameriprise Financial Franchise Advisor Deferred Equity Plan

 

Distribution expenses

 

(2

)

 

 

 

Foreign exchange

 

 

 

 

 

 

 

 

 

 

 

Seed money

 

General and administrative expense

 

 

(1

)

 

1

 

Foreign currency

 

Net investment income

 

1

 

 

1

 

 

Total other

 

 

 

 

15

 

(1

)

15

 

Total derivatives

 

 

 

$

(42

)

$

37

 

$

(97

)

$

(14

)

 

 

(1) The fair values of GMWB and GMAB embedded derivatives fluctuate based on changes in equity, interest rate and credit markets.

 

The Company holds derivative instruments that either do not qualify or are not designated for hedge accounting treatment. These derivative instruments are used as economic hedges of equity, interest rate, credit and foreign currency exchange rate risk related to various products and transactions of the Company.

 

The majority of the Company’s annuity contracts contain GMDB provisions, which may result in a death benefit payable that exceeds the contract accumulation value when market values of customers’ accounts decline. Certain annuity contracts contain GMWB or GMAB provisions, which guarantee the right to make limited partial withdrawals each contract year regardless of the volatility inherent in the underlying investments or guarantee a minimum accumulation value of consideration received at the beginning of the contract period, after a specified holding period, respectively. The Company economically hedges the exposure related to non-life contingent GMWB and GMAB provisions primarily using various futures, options, total return swaps, interest rate swaptions, interest rate swaps, variance swaps and credit default swaps. At June 30, 2011 and December 31, 2010, the gross notional amount of derivative contracts for the Company’s GMWB and GMAB provisions was $67.9 billion and $55.5 billion, respectively. The Company had previously entered into a limited number of derivative contracts to economically hedge equity exposure related to GMDB provisions on variable annuity contracts written in 2009. As of both June 30, 2011 and December 31, 2010, the Company did not have any outstanding hedges on its GMDB provisions.

 

The deferred premium associated with some of the above options is paid or received semi-annually over the life of the option contract. The following is a summary of the payments the Company is scheduled to make and receive for these options:

 

 

 

Premiums Payable

 

Premiums Receivable

 

 

 

(in millions)

 

2011(1)

 

$

151

 

$

21

 

2012

 

285

 

40

 

2013

 

262

 

25

 

2014

 

236

 

22

 

2015

 

212

 

21

 

2016-2026

 

813

 

38

 

 

 

(1) 2011 amounts represent the amounts payable and receivable for the period from July 1, 2011 to December 31, 2011.

 

Actual timing and payment amounts may differ due to future contract settlements, modifications or exercises of options prior to the full premium being paid or received.

 

Equity indexed annuities and stock market certificate products have returns tied to the performance of equity markets. As a result of fluctuations in equity markets, the obligation incurred by the Company related to equity indexed annuities and stock market certificate products will positively or negatively impact earnings over the life of these products. As a means of economically hedging its obligations under the provisions of these products, the Company enters into index options and futures contracts. The gross notional amount of these derivative contracts was $1.4 billion and $1.5 billion at June 30, 2011 and December 31, 2010, respectively.

 

The Company enters into forward contracts, futures and total return swaps to manage its exposure to price risk arising from seed money investments in proprietary investment products. The gross notional amount of these contracts was $152 million and $174 million at June 30, 2011 and December 31, 2010, respectively.

 

The Company enters into foreign currency forward contracts to economically hedge its exposure to certain receivables and obligations denominated in non-functional currencies. The gross notional amount of these contracts was $24 million and $21 million at June 30, 2011 and December 31, 2010, respectively.

 

In the first quarter of 2010, the Company entered into a total return swap to economically hedge its exposure to equity price risk of Ameriprise Financial, Inc. common stock granted as part of its Ameriprise Financial Franchise Advisor Deferred Equity Plan. In the fourth quarter of 2010, the Company extended the contract through 2011. As part of the contract, the Company expects to cash settle the difference between the value of a fixed number of shares at the contract date (which may be increased from time to time) and the value of those shares over an unwind period ending on December 31, 2011. The gross notional value of this contract was $35 million at both June 30, 2011 and December 31, 2010.

 

Embedded Derivatives

 

Certain annuities contain GMAB and non-life contingent GMWB provisions, which are considered embedded derivatives. In addition, the equity component of the equity indexed annuity and stock market certificate product obligations are also considered embedded derivatives. These embedded derivatives are bifurcated from their host contracts and reported on the Consolidated Balance Sheets at fair value with changes in fair value reported in earnings. As discussed above, the Company uses derivatives to mitigate the financial statement impact of these embedded derivatives.

 

Cash Flow Hedges

 

The Company has designated and accounts for the following as cash flow hedges: (i) interest rate swaps to hedge interest rate exposure on debt, (ii) interest rate lock agreements to hedge interest rate exposure on debt issuances and (iii) swaptions used to hedge the risk of increasing interest rates on forecasted fixed premium product sales. The Company previously designated and accounted for as cash flow hedges interest rate swaps to hedge certain asset-based distribution fees.

 

During the second quarter of 2011, the Company reclassified from accumulated other comprehensive income into earnings a $27 million gain on an interest rate hedge put in place in anticipation of issuing debt between December 2010 and June 2011.  The gain was reclassified due to the forecasted transaction not occurring according to the original hedge strategy. For the three months and six months ended June 30, 2011, amounts recognized in earnings related to cash flow hedges due to ineffectiveness were not material. The estimated net amount of existing pretax losses on June 30, 2011 that the Company expects to reclassify to earnings within the next twelve months is $1 million, which consists of $5 million of pretax gains to be recorded as a reduction to interest and debt expense and $6 million of pretax losses to be recorded in net investment income. The following tables present the impact of the effective portion of the Company’s cash flow hedges on the Consolidated Statements of Operations and the Consolidated Statements of Equity:

 

 

 

Amount of Gain (Loss) Recognized in

 

 

 

Other Comprehensive Income on Derivatives

 

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

Derivatives designated as hedging instruments

 

2011

 

2010

 

2011

 

2010

 

 

 

(in millions)

 

Interest on debt

 

$

 

$

 

$

 

$

(10

)

Asset-based distribution fees

 

 

9

 

1

 

9

 

Total

 

$

 

$

9

 

$

1

 

$

(1

)

 

 

 

Amount of Gain (Loss) Reclassified from Accumulated

 

 

 

Other Comprehensive Income into Income

 

Location of Gain (Loss) Reclassified from Accumulated

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

Other Comprehensive Income into Income

 

2011

 

2010

 

2011

 

2010

 

 

 

(in millions)

 

Other revenues

 

$

27

 

$

 

$

27

 

$

 

Interest and debt expense

 

1

 

2

 

2

 

4

 

Distribution fees

 

4

 

 

9

 

 

Net investment income

 

(2

)

(1

)

(3

)

(3

)

Total

 

$

30

 

$

1

 

$

35

 

$

1

 

 

Currently, the longest period of time over which the Company is hedging exposure to the variability in future cash flows is 24 years and relates to forecasted debt interest payments.

 

Fair Value Hedges

 

During the first quarter of 2010, the Company entered into and designated as fair value hedges three interest rate swaps to convert senior notes due 2015, 2019 and 2020 from fixed rate debt to floating rate debt. The swaps have identical terms as the underlying debt being hedged so no ineffectiveness is expected to be realized. The Company recognizes gains and losses on the derivatives and the related hedged items within interest and debt expense. The following table presents the amounts recognized in income related to fair value hedges:

 

 

 

 

 

Amount of Gain Recognized in Income on Derivatives

 

Derivatives designated

 

Location of Gain

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

as hedging instruments

 

Recorded into Income

 

2011

 

2010

 

2011

 

2010

 

 

 

 

 

(in millions)

 

(in millions)

 

Fixed rate debt

 

Interest and debt expense

 

$

10

 

$

 

$

20

 

$

6

 

Total

 

 

 

$

10

 

$

 

$

20

 

$

6

 

 

Credit Risk

 

Credit risk associated with the Company’s derivatives is the risk that a derivative counterparty will not perform in accordance with the terms of the applicable derivative contract. To mitigate such risk, the Company has established guidelines and oversight of credit risk through a comprehensive enterprise risk management program that includes members of senior management. Key components of this program are to require preapproval of counterparties and the use of master netting arrangements and collateral arrangements whenever practical. As of June 30, 2011 and December 31, 2010, the Company held $105 million and $98 million, respectively, in cash and cash equivalents and recorded a corresponding liability in other liabilities for collateral the Company is obligated to return to counterparties. As of June 30, 2011 and December 31, 2010, the Company had accepted additional collateral consisting of various securities with a fair value of $3 million and $23 million, respectively, which are not reflected on the Consolidated Balance Sheets. As of June 30, 2011 and December 31, 2010, the Company’s maximum credit exposure related to derivative assets after considering netting arrangements with counterparties and collateral arrangements was approximately $14 million and $45 million, respectively.

 

Certain of the Company’s derivative instruments contain provisions that adjust the level of collateral the Company is required to post based on the Company’s debt rating (or based on the financial strength of the Company’s life insurance subsidiaries for contracts in which those subsidiaries are the counterparty). Additionally, certain of the Company’s derivative contracts contain provisions that allow the counterparty to terminate the contract if the Company’s debt does not maintain a specific credit rating (generally an investment grade rating) or the Company’s life insurance subsidiary does not maintain a specific financial strength rating. If these termination provisions were to be triggered, the Company’s counterparty could require immediate settlement of any net liability position. At June 30, 2011 and December 31, 2010, the aggregate fair value of all derivative instruments in a net liability position containing such credit risk features was $384 million and $412 million, respectively. The aggregate fair value of assets posted as collateral for such instruments as of June 30, 2011 and December 31, 2010 was $361 million and $406 million, respectively. If the credit risk features of derivative contracts that were in a net liability position at June 30, 2011 and December 31, 2010 were triggered, the additional fair value of assets needed to settle these derivative liabilities would have been $23 million and $6 million, respectively.